Posted in | News | Manganese | Mining Business

Maxtech Closes Arms-Length Binding Agreement to Acquire Additional Mineral Claims in Brazil

Maxtech Ventures Inc. (CSE: MVT) (CSE: MVT.CN) (FRANKFURT: M1N) (OTC PINK: MTEHF) ("Maxtech" or the "Company") is pleased to announce that it has closed an arms-length binding agreement to acquire 9,999.23 hectares of additional mineral claims with indications of manganese in the State of Amazonas, Brazil.

The terms of the acquisition include the payment of US$35,000 and the issuance of 300,000 common shares of Maxtech, the transaction is subject to the CSE and other regulatory body approvals. Maxtech has now amassed over 50,000 hectares of exploration claims in the region.

Amazonas is a state in Brazil located in the northwestern corner of the country, it is the largest Brazilian State by area and the 9th largest country subdivision in the world, being greater than the areas of Uruguay, Paraguay, and Chile combined. Export of mineralized materials from the claim area could be done by truck to river transportation by barge to the Port of Manaus, in Amazonas. Manaus is an important commercial center for ocean-going vessels traveling the Amazon and is the main transport hub for the entire upper Amazon basin, with access to the Atlantic ocean for exporting products globally.

The manganese mineralization observed in the area is similar to the Company's Juina claim areas in Mato Grosso and the Espigao area of the State of Rondonia. Extensive exploration is planned for both hydrothermal vein style deposits and colluvium rich, clast deposits.

Maxtech, CEO Peter Wilson states, "The size of the surface showings are significant with cobbles the size of a small car. We are very excited to have again expanded our direct ownership with claims in Amazonas. The Company continues to grow with our goal to be one of the largest explorers for manganese claims in Brazil."

Source: http://www.maxtech-ventures.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.